<DOC>
	<DOCNO>NCT02588820</DOCNO>
	<brief_summary>Pilot study evaluate impact extremely early ART dynamic viral reservoir , immune activation inflammation patient HIV-1 infection less 20 day ( Fiebig stage I-II ) compare patient infection 20-100 day ( Fiebig stage III-V ) , induce HIV functional cure .</brief_summary>
	<brief_title>Impact Extremely Early Antiretroviral Therapy Reduce VIral REservoir Induce Functional CURE HIV-1 Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Men sex men Male 's between18 65 year old Less 100 day infection Patient stage Fiebig I V Negative Incomplete western blot negative p31 band P31 positive band western blot Positive Delta32 CCR5 mutation , HLAB5701 HLAB27 ( Â´late ' exclusion criterion ) Active oncological disease Active hepatitis C virus infection</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>HIV</keyword>
</DOC>